Moon Shot co-leader Guillermo Garcia - Manero discusses the biology and challenges of of myelodysplastic syndrome. (mdanderson.org)
In a process called cellular reprogramming, researchers at Icahn School of Medicine at Mount Sinai have taken mature blood cells from patients with myelodysplastic syndrome (MDS) and reprogrammed them back into iPSCs to study the genetic origins of this rare blood cancer. (sciencedaily.com)
Thalidomide is being studied, either as a single agent or in combination with other medicines, for treating of myelodysplastic syndromes (MDS). (aamds.org)